1.
Hassan M, Shah P, Maher B, Javidi D, Patel M, Alhoda M, Iqbal S, Stevens R. Beyond weight loss: the long-term effects of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis and fibrosis regression. Int J Res Med Sci [Internet]. 2026 Oct. 31 [cited 2026 Nov. 1];14(11):5321-3. Available from: https://www.msjonline.org/index.php/ijrms/article/view/17616